Background . The rationale and lessons learned through the evolution of the National Survey
for the Susceptibility of Bacteroides fragilis Group from its initiation in 1981 through 2007 …

Background Candidaemia is often treated with fluconazole in the absence of susceptibility
testing. We examined factors associated with candidaemia caused by Candida isolates with …

Purpose: To replicate research about confidence level in receiving health teaching from either
an overweight or a weight‐appropriate RN. Methods: A quasi‐experimental post‐test only …

The novel fluorocycline antibiotic eravacycline is in development for use in the treatment of
serious infections caused by susceptible and multidrug-resistant (MDR) aerobic and …

We evaluated in vitro activity of ceftolozane-tazobactam (TOL-TAZ), formerly CXA-201,
against recent clinical anaerobic isolates with emphasis on the Bacteroides fragilis group. …

Background: Several newer generation fluoroquinolones have demonstrated good in vitro
activity against Bacteroides species; particularly when first introduced. However, resistance of …

Importance The Zika virus epidemic has been declared a public health emergency of international
concern by the World Health Organization. We describe the mucocutaneous features …

The rising incidence of Clostridium difficile infections (CDIs) in adults is partly related to the
global spread of fluoroquinolone-resistant strains, namely, BI/NAP1/027. Although CDIs are …

Objectives We evaluated the antimicrobial susceptibility and ribotypes of Clostridium difficile
isolates from participants in a Phase 2 study of ridinilazole, a novel targeted-spectrum agent …

We evaluated the in vitro activity of imipenem-relebactam (imipenem-MK7655) against 451
recent clinical isolates within the Bacteroides group and related species. Relebactam did not …